Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac vs Placebo for Ocular Inflammation and Pain in Cataract Surgery
NCT00333918Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Jun 2006
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bromfenac sodium in ocular inflammation, sponsored by Bausch + Lomb. Started Jun 2006; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT00333918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00333918.